OncoVista Innovative Therapies, Inc. Reports Sharply Higher Q1 Revenues
SAN ANTONIO--(BUSINESS WIRE)--OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable safe, targeted personal cancer treatments, today announced a significant rise in first quarter 2010 revenues as compared to first quarter 2009.